Evidence map›Paper›PMID 30412793›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2020

Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signaling.

Daniela N Rolph, Moonmoon Deb, Suman Kanji, Carl J Greene, Manjusri Das, Matthew Joseph, Reeva Aggarwal, Binnaz Leblebicioglu, Hiranmoy Das

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Consequences of Aging on Bone.Aging and disease · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Plants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Daniela N RolphDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Moonmoon DebDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Suman KanjiDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Carl J GreeneDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Manjusri DasDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH, USA.
Matthew JosephDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH, USA.
Reeva AggarwalDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH, USA.
Binnaz LeblebiciogluDivision of Periodontology, College of Dentistry, The Ohio State University, Columbus, OH, USA.
Hiranmoy DasDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH, USA. Electronic address: hiranmoy.das@ttuhsc.edu.
Texas Tech University · USThe Ohio State University Wexner Medical Center · USThe Ohio State University · US

Funding

Myeloid KLF2 regulation mechanisms in rheumatoid arthritisR01AR068279 · NIAMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI DAS, HIRANMOY · 2016 to 2022
$1.7M
Corneal Endothelial Stem Cells for Treatment of Corneal Endothelial DystrophiesR41EY024217 · NEI · RASHMIVU, LLC · PI DAS, HIRANMOY · 2014 to 2016
$268k
Nanofiber Expanded CD34+ Stem Cells for Osteoporosis TherapyR41AG057242 · NIA · HNB THERAPEUTICS, LLC · PI DAS, HIRANMOY · 2018 to 2018
$225k
NEI NIH HHS R41 EY024217NIAMS NIH HHS R01 AR068279NIA NIH HHS R41 AG057242
6 · The paper itself

Abstract

Osteoporosis is a silent systemic disease that causes bone deterioration, and affects over 10 million people in the US alone. This study was undertaken to develop a potential stem cell therapy for osteoporosis. We have isolated and expanded human dental pulp-derived stem cells (DPSCs), characterized them, and confirmed their multipotential differentiation abilities. Stem cells often remain quiescent and require activation to differentiate and function. Herein, we show that ferutinin activates DPSCs by modulating the Wnt/β-catenin signaling pathway and key osteoblast-secreted proteins osteocalcin and collagen 1A1 both mRNA and protein levels. To confirm that ferutinin modulates the Wnt pathway, we inhibited glycogen synthase kinase 3 (GSK3) and found that protein expression patterns were similar to those found in ferutinin-treated DPSCs. To evaluate the role of ferutinin in epigenetic regulation of canonical Wnt signaling, the pathway molecules Wnt3a and Dvl3 were analyzed using chromatin immunoprecipitation (ChIP)-quantitative PCR approaches. We confirmed that active marks of both H3K9 acetylation and H3K4 trimethylation were significantly enhanced in the promoter sites of the WNT3A and DVL3 genes in DPSCs after addition of ferutinin. These data provide evidence that ferutinin activates and promotes osteogenic differentiation of DPSCs, and could be used as an inducer as a potentially effective stem cell therapy for osteoporosis.

Indexed as

BenzoatesBridged Bicyclo CompoundsCycloheptanesDental PulpEpigenesis, GeneticHumansOsteogenesisSesquiterpenesStem CellsWnt Signaling Pathway4-oxy-6-(4-oxybezoyloxy)dauc-8,9-enBenzoatesBridged Bicyclo CompoundsCycloheptanesSesquiterpenesDPSCEpigenetic regulationFerutininOsteogenic differentiationWnt/β-catenin

Identifiers

PMID30412793
PMCPMC6502698
OpenAlexW2900419744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.